Evidence map›Paper›PMID 27796741›Full record

ReviewInternational journal of hematology2017

SET/MLL family proteins in hematopoiesis and leukemia.

Weiwei Yang, Patricia Ernst

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in International journal of hematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. The MLL/SET family and haematopoiesis.Biochimica et biophysica acta. Gene regulatory mechanisms · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Weiwei YangDepartment of Pediatrics and Pharmacology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, CO, 80045, USA.
Patricia ErnstDepartment of Pediatrics and Pharmacology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, CO, 80045, USA. patricia.ernst@ucdenver.edu.ORCID http://orcid.org/0000-0001-7638-2939
Dartmouth College · USUniversity of Colorado Anschutz Medical Campus · US

Funding

MLL Function in the Maintenance of the Blood Forming SystemR01HL090036 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ERNST, PATRICIA · 2007 to 2015
$3.8M
Modeling hematologic malignancy and self-renewal with gain-of-function MLL1R21OD019716 · OD · UNIVERSITY OF COLORADO DENVER · PI BRYDER, DAVID, ERNST, PATRICIA · 2014 to 2015
$431k
NHLBI NIH HHS R01 HL090036NIH HHS R21 OD019716
6 · The paper itself

Abstract

Accumulating recent evidence supports the notion that many enzymes that modify histones are fundamental players in normal hematopoiesis as well as hematologic malignancies, and represent an important new class of drug targets. Histone H3 lysine 4 (H3K4) methylation plays several distinct roles in gene expression and is modulated by specific methyltransferases and demethylases. Recent progress has been made clarifying the unique biological roles of the enzymes that carry out H3K4 methylation, yet a detailed understanding of H3K4 methylation states in various genomic contexts and the diverse functions of the enzymes that perform these methylation events is incomplete, but developing rapidly. In this review, we summarize and discuss the general mechanisms of H3K4 methylation, and how the six main enzymes from the SET/MLL family (responsible for H3K4me1/me2/me3) function in hematopoiesis and in hematologic malignancies.

Indexed as

HematopoiesisAnimalsDNA-Binding ProteinsHistone ChaperonesHistone-Lysine N-MethyltransferaseHistonesHumansLeukemiaMethylationMyeloid-Lymphoid Leukemia ProteinProtein Interaction MapsTranscription FactorsDNA-Binding ProteinsHistone ChaperonesHistone-Lysine N-MethyltransferaseHistonesKMT2A protein, humanMyeloid-Lymphoid Leukemia ProteinSET protein, humanTranscription FactorsAMLH3K4 methylationHistone methyltransferaseLeukemiaMLL1MLL2Wbp7

Identifiers

PMID27796741
OpenAlexW2542325546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.